Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140031/S199

Edwards Commander Delivery System (9600LDS20, 9600LDS23, 9600LDS26, 9600LDS29, 9750CM20, 9750CM23, 9750CM26)

Edwards Lifesciences, LLC · Decision date Feb 12, 2026

FDA DECISIONP140031/S199

What did the FDA decide?

FDA records P140031/S199 as a supplement to PMA P140031, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 12, 2026.

FDA approval order statement

a change in sub-tier supplier for a raw material used in tubing components of the EVOQUE Tricuspid Delivery System and the Commander Delivery System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Feb 12, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P140031/S199
Regulatory pathway
PMA supplement
Product code
NPT
Decision code
OK30
Decision date
Feb 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic valve, prosthesis, percutaneously delivered.

Product code
NPT
FDA device class
3

For the original device and its historical approval scope, see PMA P140031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140031 · Original PMA

    SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

  2. P140031/S193 · Related supplement

    Edwards Commander Delivery System: 9600LDS23, 9600LDS26, 9600LDS29 9750CM23, 9750CM26, 9750CM29

  3. P140031/S194 · Related supplement

    SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

  4. P140031/S195 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra RES

  5. P140031/S196 · Related supplement

    Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (sizes 20mm, 23mm, 26mm) 9750TFX; Edwards SAPIEN 3 Ultra RESILIA Transc

  6. P140031/S197 · Related supplement

    Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve, Models 9755RSL20, 9755RSL23, 9755RSL26, and 9755RSL29

  7. P140031/S199 received

    Application receipt date recorded by FDA.

  8. P140031/S189 · Related supplement

    Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve

  9. P140031/S199 · FDA decision

    30-Day Notice

  10. P140031/S200 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra

  11. P140031/S198 · Related supplement

    SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

  12. P140031/S201 · Related supplement

    Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve, SAPIEN 3 Ultra Transcatheter Heart Valve System

  13. P140031/S203 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve System

  14. P140031/S204 · Related supplement

    Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve

  15. P140031/S205 · Related supplement

    Edwards Commander Delivery System (9600LDS20; 9600LDS23; 9600LDS26; 9600LDS29; 9750CM20; 9750CM23; 9750CM26; 9750CM29)

  16. P140031/S206 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra Transcatheter Heart Valve; Edwards SAPIEN 3 Ultra RES

  17. P140031/S192 · Related supplement

    Edwards Crimper: 9600CR

  18. P140031/S207 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX20, 9600TFX23, 9600TFX26, 9600TFX29); Edwards SAPIEN 3 Ultra Transcat

  19. P140031/S208 · Related supplement

    Edwards Certitude Delivery System (9600SDS20, 9600SDS23, 9600SDS26, 9600SDS29, 9630TA20, 9630TA23, 9630TA26, 9630TA29);

  20. P140031/S209 · Related supplement

    Edwards Crimper (9600LDS23, 9600LDS26, 9600LDS29, 9750CM20, 9750CM23, 9750CM26, 9750CM29)

  21. P140031/S202 · Related supplement

    Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve

  22. P140031/S210 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX), Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (9750TFX)

Timeline entries are records held by MedtechLedger for P140031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140031

Product / regulatory recordCompanyPathwayDecision dateSource
Edwards Lifesciences, LLCPMA approvalJun 17, 2015FDA
Edwards Lifesciences, LLCPMA supplementOct 2, 2025FDA
Edwards Lifesciences, LLCPMA supplementOct 10, 2025FDA
Edwards Lifesciences, LLCPMA supplementOct 16, 2025FDA
Edwards Lifesciences, LLCPMA supplementDec 17, 2025FDA
Edwards Lifesciences, LLCPMA supplementDec 17, 2025FDA
Edwards Lifesciences, LLCPMA supplementFeb 3, 2026FDA
Edwards Lifesciences, LLCPMA supplementMar 11, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 9, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 16, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 30, 2026FDA
Edwards Lifesciences, LLCPMA supplementJun 3, 2026FDA
Edwards Lifesciences, LLCPMA supplementJun 30, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 2, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 17, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 28, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 29, 2026FDA
Edwards Lifesciences, LLCPMA supplementSep 23, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 22, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 28, 2026FDA

Explore the linked device profile

Other records with product code NPT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records